制药技术的新进展New Development of Pharmaceutical Technologies
林卓辉,谭载友,朱尔佳,曹蕾,詹珊珊,周贵宝
LIN Zhuo-hui1 ,TAN Zai-you1,2 ,ZHU Er-jia1,CAO Lei1 ,ZHAN Shan-shan2
摘要(Abstract)：
目的发现和推广最新的制药技术。方法从医药文献和专利网络分析制药技术信息。结果确定五项创新的医药技术:口服蛋白质技术、大分子吸收促进剂、转晶技术、Raltegravir的绿色生产流程、免疫球蛋白的双靶点理论和多抗体大分子实体技术。结论这五项创新技术对制药业未来发展非常重要。
Objective To find and promote the new pharmaceutical technologies. Methods The information of the development of pharmaceutical technology from work-net was analyzed. Results A total of 5 new technologies were reviewed:orally therapeutic proteins,macromolecular absorption enhancers,solid complexes with ionic polymers,green process design of Raltegravir,and dual-variable domain immunoglobulin (DVD-Ig). Conclusion These 5 technologies are very important in the future of pharmaceutical industry.
关键词(KeyWords)：
口服治疗蛋白质技术;大分子吸收促进剂;转晶技术;绿色生产流程;免疫球蛋白双靶点理论;多抗体大分子实体
orally therapeutic proteins; macromolecular absorption enhancers; solid complexes with ionic polymers; green process; dual-variable domain immunoglobulin
基金项目(Foundation):
作者(Author):
林卓辉,谭载友,朱尔佳,曹蕾,詹珊珊,周贵宝
LIN Zhuo-hui1 ,TAN Zai-you1,2 ,ZHU Er-jia1,CAO Lei1 ,ZHAN Shan-shan2
参考文献(References)：
- 1Borrelly Gilles,Drittanti Lila,Manuel Vega,et al.Oral dosage formulations of protease-resistant polypetides.2008,U.S.patent:20080260820.
- 2http://www.nautilusbiotech.com/prods_1_1.html
- 3http://www.nautilusbiotech.com/prods_1_2.html
- 4Meezan,et al.Absorption enhancers for drug administration.1997,U.S.patent:08/083,074.
- 5Pillion DJ,Gargiulo C,Wang RX,Meezan E,et al.Insulin delivery in nosedrops:new fomulations containing alkylglycosidesEndocrinology,1994,135(6):2386-91.
- 6Albano;Antonio A.(Clifton,NJ);Phuapradit,et al.Stablecomplexes of poorly soluble compounds in ionic polymers.1999,U.S.patent:6,350,786.
- 7http://www.epa.gov/greenchemistry/pubs/docs/award_entries_and_recipients2008.pdf
- 8Wu Chengbin,Ghayur Tariq,Dixon Richard W,et al.Dual variable domain immunoglobulin and uses thereof.2007,U.S.patent:20070071675.
- 9Wu Chengbin,Ying H,Grinnell C,et al.Simultaneous targetingof multiple disease mediators by a dual-variable-domain immunoglobulin.Nature Biotechnology,2007,25:1290-1297.